Humana Inc. saw its stock drop over 21% after the Trump administration proposed nearly flat Medicare Advantage reimbursement rates for 2027, exacerbating a year-to-date decline of 26.64%. This sell-off highlights broader concerns in the insurance market, with major companies like UnitedHealth also facing double-digit declines. Analysts project that these proposed changes may negatively impact Humana's revenue and profit margins, despite the company's recent reporting of $32.65 billion in quarterly revenue and a robust market cap of $23.65 billion.
“HUMANA · plunged · -21% · after proposed flat Medicare Advantage reimbursement rates”
“HUMANA · plunged after · the Trump administration proposed nearly flat Medicare Advantage reimbursement rates for 2027”
“HUMANA · plunged · 21% · true”
“Humana and software names like Intuit and Salesforce · bring up · the rear”
“HUMANA · plunged · -21% · after the Trump administration proposed nearly flat Medicare Advantage reimbursement rates for 2027”
“Major insurers · saw · double-digit declines · with UnitedHealth Group down 12.60% and Humana down 26.64% year-to-date”
“Humana Inc. · has · a year-to-date performance of · -26.64%”
“Humana · plunged · -21%”
“Humana · proposed · a much smaller-than-expected payment rate increase for Medicare Advantage plans · Centers for Medicare & Medicaid Services (CMS)”
“Humana and software names like Intuit and Salesforce · bring up · the rear”
“Humana · has · market cap · $23.65 billion”
“Humana · provides · health insurance plans · to approximately 17 million members”
